Readings Newsletter
Become a Readings Member to make your shopping experience even easier.
Sign in or sign up for free!
You’re not far away from qualifying for FREE standard shipping within Australia
You’ve qualified for FREE standard shipping within Australia
The cart is loading…
This title is printed to order. This book may have been self-published. If so, we cannot guarantee the quality of the content. In the main most books will have gone through the editing process however some may not. We therefore suggest that you be aware of this before ordering this book. If in doubt check either the author or publisher’s details as we are unable to accept any returns unless they are faulty. Please contact us if you have any questions.
Because of their therapeutic safety, hydroxyethylstarch, gelatin and dextrans are among the most frequently used drugs in the world. Studies have shown that the bleeding disorders, anaphylactic reactions and storage in the body depend on the nature of the administered plasma substitute. Through interdisciplinary co-operation the First European Volume Replacement Conference has established indications for the use of individual plasma substitutes to improve the efficacy and therapeutic safety of volume replacement therapy.
$9.00 standard shipping within Australia
FREE standard shipping within Australia for orders over $100.00
Express & International shipping calculated at checkout
This title is printed to order. This book may have been self-published. If so, we cannot guarantee the quality of the content. In the main most books will have gone through the editing process however some may not. We therefore suggest that you be aware of this before ordering this book. If in doubt check either the author or publisher’s details as we are unable to accept any returns unless they are faulty. Please contact us if you have any questions.
Because of their therapeutic safety, hydroxyethylstarch, gelatin and dextrans are among the most frequently used drugs in the world. Studies have shown that the bleeding disorders, anaphylactic reactions and storage in the body depend on the nature of the administered plasma substitute. Through interdisciplinary co-operation the First European Volume Replacement Conference has established indications for the use of individual plasma substitutes to improve the efficacy and therapeutic safety of volume replacement therapy.